Migraines, nerve damage: The Australians poisoned by over-the-counter vitamins
Vitamin B6 is an essential nutrient found naturally in meat and plant sources, and occasionally added to popular over-the-counter supplements to aid the metabolic process.
It has generally been considered toxic only when consumed in high doses over a long period, but the Therapeutic Goods Administration (TGA) last month noted there was no scientific consensus on a safe threshold. Symptoms include nausea, hypersensitivity and nerve damage that can lead to tingling, burning and numbness throughout the body.
Melbourne injury law firm Polaris Lawyers announced in May that it was pursuing a class action investigation against Blackmores on behalf of anyone who has suffered injuries after taking its supplements 'containing higher than recommended levels of vitamin B6'.
The firm's principal, Nick Mann, said the response had been overwhelming, with more than 300 inquiries into joining the potential suit. The majority of respondents suffered injuries after taking Blackmores supplements containing vitamin B6, either exclusively or alongside supplements made by other companies, he said.
Loading
'One of the things that surprised me has been the number of people who've told us about really significant and ongoing impacts of basic toxicity long after they've ceased taking the supplement,' Mann said. 'The impacts on them have been permanent and ongoing.'
A Blackmores spokesperson said all its products, including those containing vitamin B6, are developed 'in strict accordance' with the TGA's regulatory requirements.
Mann said companies had a duty to protect customers and there was strong precedent for successful legal claims against the manufacturers of products approved by regulators but later proven to be harmful.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
West Australian
10 hours ago
- West Australian
Testosterone cream developed in WA revolutionises treatment for menopausal women but at treble the price
A testosterone cream developed in WA is revolutionising the way doctors treat a common side effect of menopause. But the medication is not listed on the Pharmaceutical Benefits Scheme and costs three times more than the men's version of the product. Androfeme is the only testosterone cream in Australia approved by the Therapeutic Goods Administration to treat hypo-active sexual desire dysfunction — a common side effect of menopause responsible for a distressing loss of libido. Doctors and pharmacists have labelled medication a game changer but it's inaccessible to many women as it's not listed on the PBS, costing $100 for a tube that lasts 100 days. The equivalent treatment for men is on the PBS and costs less than a third of the price at $31.60. When mum-of-two Jane Capelli turned 40, she experienced hot flushes, insomnia, irritability, headaches, and zero libido. 'I didnt feel like my old self, something was missing,' she said. Her hormone levels plummeted while she was in the midst of perimenopause. Her doctor prescribed hormone replacement therapy but it was the testosterone cream, Androfeme, that made the biggest difference. 'I feel like my old self again, energy and clarity have improved, the fog feels like its lifting,' she said. Doctors hope Androfeme will be added to the PBS this year to help women like Ms Capelli. Lawley Pharmaceuticals pharmacist Michael Buckley said the product was a 'game changer' for women. 'Up until then women didn't have a female specific testosterone treatment and if they were going to be treated they were forced to use male products that couldn't be measured easily,' she said. General practitioner Lucy Caratti said testosterone had a huge impact on women's health. 'Testosterone is a huge player in women and it's been very much overlooked, been thought of as very much a male hormone, but we know its effects on the brain, heart, bones and of course the libido,' she said. 'Women are already paying quite a lot for their estrogen and progesterone so being able to subsidise some of the testosterone will make a really big difference for people to be able to afford it.' The company behind Androfeme is conducting trials to measure the impact of testosterone cream on other common menopause side effects including bone loss, loss of muscle strength and brain fog. If the results are positive, the cream could eventually be used to treat those symptoms.
Perth Now
4 days ago
- Perth Now
‘Toxic' claim against supplement giant
Australian supplement giant Blackmores is facing potential class-action lawsuit, over claims that excessive levels of vitamin B6 in some of the company's over-the-counter products have led to serious health complications. Dominic Noonan-O'Keeffe began taking Blackmores supplements in May 2023 to support his health, ahead of the birth of his first child. Unaware the magnesium product contained potentially 'toxic' levels of vitamin B6, he claims he soon developed severe symptoms – including fatigue, headaches, muscle spasms, heart palpitations, and loss of sensation, according to Polaris lawyers. Doctors later diagnosed him with neuropathy linked to excessive B6 intake. Despite stopping in early 2024, Mr Noonan-O'Keeffe claims he continues to suffer daily from nerve pain and other symptoms. Polaris Lawyers – who are representing Mr Noonan-O'Keeffe, the lead plaintiff in the potential class-action – allege they later discovered the magnesium product contained about 29 times the recommended daily intake of vitamin B6. Mr Noonan-O'Keeffe claims he suffered lasting health impacts after taking Blackmores Magnesium+. Supplied Credit: Supplied Polaris Lawyers is now investigating a proposed class action against Blackmores for the excessive B6 levels in their vitamin supplements. 'It's alarming to walk down the vitamin aisle of any chemist in Australia and see vitamin supplements containing levels of B6 which are far and above the recommended daily intake,' Polaris Lawyers Founder and Principal Nick Mann said. 'What happened to Dominic is tragic, but he is not alone – we are aware of reports that excessive levels of B6 in over-the-counter supplements may have caused lasting injuries to hundreds of Australians. 'Polaris Lawyers is currently investigating a class action on behalf of anyone who has suffered injuries as a result of excessive levels of B6 as a result of taking Blackmores vitamin supplements.' Blackmores is one of the country's biggest supplement providers. Supplied Credit: Supplied In an interim decision report released in June, the TGA acknowledged no clear consensus on a safe vitamin B6 level that fully prevents peripheral neuropathy. The decision proposed rescheduling products containing over 50mg per day as 'Pharmacist Only Medicines.' A Blackmores spokesperson said they were aware of the TGA's proposed changes. 'At Blackmores, we are committed to the highest standards of product quality and consumer safety. All our products, including those containing Vitamin B6, are developed in strict accordance with the regulatory requirements of the Therapeutic Goods Administration (TGA),' the spokesperson said. 'This includes compliance with maximum permitted daily doses and the inclusion of mandated warning statements. 'We acknowledge the interim decision issued by the TGA and we will ensure full compliance with its final determination.'
News.com.au
4 days ago
- News.com.au
Aussie supplement company Blackmores facing potential class action over allegedly ‘toxic' levels of B6 in products
Australian supplement giant Blackmores is facing potential class-action lawsuit, over claims that excessive levels of vitamin B6 in some of the company's over-the-counter products have led to serious health complications. Dominic Noonan-O'Keeffe began taking Blackmores supplements in May 2023 to support his health, ahead of the birth of his first child. Unaware the magnesium product contained potentially 'toxic' levels of vitamin B6, he claims he soon developed severe symptoms – including fatigue, headaches, muscle spasms, heart palpitations, and loss of sensation, according to Polaris lawyers. Doctors later diagnosed him with neuropathy linked to excessive B6 intake. Despite stopping in early 2024, Mr Noonan-O'Keeffe claims he continues to suffer daily from nerve pain and other symptoms. Polaris Lawyers – who are representing Mr Noonan-O'Keeffe, the lead plaintiff in the potential class-action – allege they later discovered the magnesium product contained about 29 times the recommended daily intake of vitamin B6. Polaris Lawyers is now investigating a proposed class action against Blackmores for the excessive B6 levels in their vitamin supplements. 'It's alarming to walk down the vitamin aisle of any chemist in Australia and see vitamin supplements containing levels of B6 which are far and above the recommended daily intake,' Polaris Lawyers Founder and Principal Nick Mann said. 'What happened to Dominic is tragic, but he is not alone – we are aware of reports that excessive levels of B6 in over-the-counter supplements may have caused lasting injuries to hundreds of Australians. 'Polaris Lawyers is currently investigating a class action on behalf of anyone who has suffered injuries as a result of excessive levels of B6 as a result of taking Blackmores vitamin supplements.' In an interim decision report released in June, the TGA acknowledged no clear consensus on a safe vitamin B6 level that fully prevents peripheral neuropathy. The decision proposed rescheduling products containing over 50mg per day as 'Pharmacist Only Medicines.' A Blackmores spokesperson said they were aware of the TGA's proposed changes. 'At Blackmores, we are committed to the highest standards of product quality and consumer safety. All our products, including those containing Vitamin B6, are developed in strict accordance with the regulatory requirements of the Therapeutic Goods Administration (TGA),' the spokesperson said. 'This includes compliance with maximum permitted daily doses and the inclusion of mandated warning statements. 'We acknowledge the interim decision issued by the TGA and we will ensure full compliance with its final determination.'
